E
ReShape Lifesciences Inc. RSLS
$0.6355 $0.00050.08%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 0.88% 27.27% -29.15% 51.95% -1.17%
Total Depreciation and Amortization -16.67% 0.00% -14.29% -86.00% 2.04%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1,107.69% 92.33% -6,680.00% -100.54% 938.18%
Change in Net Operating Assets 288.76% -43.17% 159.66% -249.08% 92.99%
Cash from Operations 77.08% 34.51% 15.67% 11.62% 58.27%
Capital Expenditure -- -- -- -- 100.00%
Sale of Property, Plant, and Equipment -- -- -- -- -100.00%
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- 100.00%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -100.00% -- -- -- -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 200.00% --
Cash from Financing -100.00% -- -- 1,715.68% -115.02%
Foreign Exchange rate Adjustments -85.71% 187.50% -233.33% -- 100.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 76.62% 36.25% -169.10% 196.54% 29.39%
Weiss Ratings